Showing results (451-460 of 3,470) with videos related to
Sort By:
Pageof 347
Clinical Pharmacokinetics|January 1, 1995
The effect of mild or moderate hepatic impairment (cirrhosis) on the pharmacokinetics of zileutonW M Awni, J H Cavanaugh, R A Braeckman, et al.Clinical Pharmacokinetics|January 1, 1995
Lack of pharmacokinetic interaction between zileuton and phenytoin in humansE Samara, J H Cavanaugh, D Mukherjee, et al.Clinical Pharmacokinetics|January 1, 1995
Assessment of the pharmacokinetic interaction between zileuton and digoxin in humansW M Awni, Z Hussein, J H Cavanaugh, et al.Clinical Pharmacokinetics|February 12, 2004
Pharmacokinetics of Ibuprofen in children with cystic fibrosisEmily E Han, Paul M Beringer, Stan G Louie, et al.Clinical Pharmacokinetics|October 29, 2004
Pharmacokinetics of tocolytic agentsVassilis Tsatsaris, Dominique Cabrol, Bruno CarbonneClinical Pharmacokinetics|October 29, 2004
Bicalutamide: clinical pharmacokinetics and metabolismIan D CockshottClinical Pharmacokinetics|June 2, 2004
Effect of haemodialysis on the pharmacokinetics of antineoplastic drugsMasatoshi Tomita, Yoichi Aoki, Kenichi TanakaClinical Pharmacokinetics|August 11, 2004
Clinical pharmacokinetics of levetiracetamPhilip N PatsalosClinical Pharmacokinetics|August 11, 2004
Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipientsDirk R J Kuypers, Kathleen Claes, Pieter Evenepoel, et al.Clinical Pharmacokinetics|July 13, 2004
Tazarotene does not affect the pharmacokinetics and efficacy of a norethindrone/ethinylestradiol oral contraceptiveZhiling Yu, Dale Yu, Patricia S Walker, et al.Pageof 347